1. Home
  2. VXRT

VXRT

Vaxart Inc

Logo Vaxart Inc

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Founded: N/A Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 158.1M IPO Year: N/A
Target Price: $3.00 AVG Volume (30 days): 1.9M
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.57 EPS Growth: N/A
52 Week Low/High: $0.53 - $1.59 Next Earning Date: 05-02-2024
Revenue: $7,379,000 Revenue Growth: 6796.26%
Revenue Growth (this year): 103.66% Revenue Growth (next year): 56.79%

Share on Social Networks: